How to Get Vardenafil (Levitra/Staxyn) in Arizona

At a glance
- Drug / vardenafil (Levitra, Staxyn), PDE5 inhibitor for erectile dysfunction
- Prescription required / yes, Schedule-unscheduled but Rx-only in all 50 states
- Arizona telehealth prescribing / fully legal for ED medications
- 503A compounding / available in Arizona with a patient-specific prescription
- Arizona Medicaid / does not cover vardenafil for ED
- Standard dose / 10 mg taken 30 to 60 minutes before sexual activity, max 20 mg/day
- Onset of action / 25 to 60 minutes; duration 4 to 5 hours
- Generic availability / yes, since 2018 (patent expiry)
- Prescriber types / MD, DO, NP (with prescriptive authority), PA (with supervising physician)
- FDA approval / 2003 for erectile dysfunction
Arizona Telehealth Prescribing Rules for Vardenafil
Arizona allows licensed prescribers to evaluate, diagnose, and prescribe erectile dysfunction medications like vardenafil through synchronous telehealth visits. The Arizona Medical Board and the Arizona State Board of Nursing both recognize audio-video consultations as sufficient for establishing the prescriber-patient relationship required before writing an Rx.
Under Arizona Revised Statutes Title 36, Chapter 36 (Telehealth), providers must hold an active Arizona license or be registered through the Interstate Medical Licensure Compact. A 2021 update to ARS 36-3602 removed the prior requirement for an in-person visit before a telehealth prescription, which means a first-time patient can complete the entire process remotely. The prescriber conducts a focused sexual health history, screens for cardiovascular contraindications, reviews current medications for nitrate or alpha-blocker interactions, and sends the prescription electronically to a pharmacy of the patient's choice.
Several national telehealth platforms operate in Arizona and include vardenafil on their formularies. Visit costs range from $0 (subscription models that bundle the medication) to $75 for a standalone consultation. Most platforms complete the prescriber review within 24 hours of intake submission, and some offer same-day review for patients who schedule synchronous video appointments.
The FDA-approved prescribing information for vardenafil specifies that the drug should not be co-administered with nitrates in any form or with potent CYP3A4 inhibitors like ritonavir [1]. Telehealth prescribers in Arizona are required to document this screening in the visit note.
Who Can Prescribe Vardenafil in Arizona
Any prescriber with an active Arizona license and prescriptive authority can write a vardenafil prescription. That shortlist includes three categories of clinician.
Physicians (MD/DO): Board-certified or board-eligible physicians in family medicine, internal medicine, urology, or endocrinology most commonly prescribe PDE5 inhibitors. No specialty restriction exists. A general practitioner can prescribe vardenafil just as readily as a urologist.
Nurse Practitioners (NP): Arizona is a full-practice-authority state for NPs. Under ARS 32-1601, nurse practitioners with a Doctor of Nursing Practice (DNP) or Master of Science in Nursing (MSN) can independently evaluate and prescribe without physician oversight, including controlled and non-controlled medications. Vardenafil is not a controlled substance, so there are no DEA schedule limitations.
Physician Assistants (PA): PAs in Arizona prescribe under a collaborative practice agreement with a supervising physician. The supervising physician does not need to be physically present for each encounter, but the agreement must authorize the PA to prescribe the relevant drug class [2].
A 2003 key trial by Porst et al. (N=580) demonstrated that vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by 9.4 points versus 3.7 points for placebo (P<0.001) after 12 weeks [3]. This efficacy data underpins why the drug remains a first-line option in the AUA/SMSNA 2018 guideline for erectile dysfunction alongside sildenafil and tadalafil [4].
Labs and Screening Required Before a Prescription
No single lab panel is universally mandated before prescribing vardenafil, but clinical guidelines recommend baseline screening to rule out underlying conditions that contribute to ED and to confirm cardiovascular safety.
A standard pre-prescribing workup includes fasting glucose or HbA1c (to screen for diabetes, which affects 30 to 50% of men with ED), a fasting lipid panel, total testosterone (morning draw), and a basic metabolic panel. The Endocrine Society's 2018 guideline on testosterone therapy recommends measuring morning total testosterone in any man presenting with sexual dysfunction to rule out hypogonadism as a contributing factor [5]. If testosterone is below 300 ng/dL on two separate morning draws, testosterone replacement may be indicated alongside or instead of a PDE5 inhibitor.
Some telehealth platforms waive lab requirements for patients under 40 with no cardiovascular risk factors, relying instead on a detailed history and validated questionnaires like the IIEF-5 (Sexual Health Inventory for Men, or SHIM). Patients over 40, those with hypertension, diabetes, hyperlipidemia, or a family history of premature cardiovascular disease should expect their prescriber to request labs before initiating therapy.
An electrocardiogram (ECG) is not routinely required but may be ordered if the prescriber suspects an arrhythmia. Vardenafil can prolong the QTc interval at supratherapeutic doses, and the FDA label warns against use in patients with congenital QT prolongation or those taking Class IA or Class III antiarrhythmics [1].
How to Fill a Vardenafil Prescription in Arizona
Once you have a valid prescription, three pharmacy pathways are available in Arizona: retail chain pharmacies, independent pharmacies, and 503A compounding pharmacies.
Retail pharmacies. CVS, Walgreens, Walmart, and Costco all stock generic vardenafil tablets in Arizona. Generic vardenafil 20 mg tablets cost between $1.50 and $8.00 per tablet at retail, depending on pharmacy and discount card. GoodRx and RxSaver coupons routinely bring the price to $2.00 to $4.00 per tablet at major chains. Brand-name Levitra, if available, runs $50 to $70 per tablet without insurance.
Mail-order and online pharmacies. Licensed online pharmacies registered with the Arizona State Board of Pharmacy can ship vardenafil to any Arizona address. Platforms like Cost Plus Drugs (Mark Cuban's pharmacy) list generic vardenafil 20 mg at $3.60 for a 30-tablet supply plus a flat dispensing fee. Delivery typically takes 3 to 5 business days via USPS.
503A compounding pharmacies. Arizona licenses 503A compounding pharmacies under ARS 32-1981. These pharmacies can prepare patient-specific compounded vardenafil formulations (sublingual troches, orally disintegrating tablets, combination formulations with other ED agents) when a prescriber writes a compound-specific prescription. A compounded sublingual vardenafil troche may cost $4 to $10 per unit depending on the pharmacy and formulation. The pharmacy must hold both an Arizona Board of Pharmacy license and comply with USP 795 standards for non-sterile compounding [6].
Arizona Medicaid and Insurance Coverage
Arizona Medicaid (AHCCCS) does not cover vardenafil or any PDE5 inhibitor for erectile dysfunction. This exclusion applies to all AHCCCS managed care plans, including Mercy Care, Banner University Family Care, Arizona Complete Health, and UnitedHealthcare Community Plan.
Commercial insurance coverage varies. A 2019 analysis published in the Journal of Sexual Medicine found that approximately 44% of commercially insured men with ED had some PDE5 inhibitor coverage, though plans frequently imposed quantity limits of 6 to 12 tablets per month and required step therapy starting with sildenafil before approving vardenafil or tadalafil [7].
When insurance does cover vardenafil, expect a prior authorization process. Documentation typically required includes a chart note confirming the ED diagnosis (ICD-10 code N52.9 or more specific subcodes), documentation of failed sildenafil trial or documented contraindication, and relevant lab results. The prescriber submits this to the plan's pharmacy benefit manager (PBM), and turnaround is usually 48 to 72 hours.
For patients paying out of pocket, generic vardenafil remains one of the most affordable PDE5 inhibitors. At $2.00 to $4.00 per tablet with a discount card, a patient using 8 tablets per month spends $16 to $32 monthly.
Vardenafil vs. Other PDE5 Inhibitors Available in Arizona
Arizona patients have access to all four FDA-approved PDE5 inhibitors: sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra/Staxyn), and avanafil (Stendra). Choosing between them depends on onset speed, duration, side-effect profile, and cost.
Vardenafil occupies a middle position. Its onset (25 to 60 minutes) is comparable to sildenafil but slower than avanafil (15 to 30 minutes). Its duration (4 to 5 hours) is shorter than tadalafil (up to 36 hours) but similar to sildenafil. A head-to-head crossover study by Rubio-Aurioles et al. (2006, N=1,057) found no statistically significant difference in IIEF scores between vardenafil 20 mg and sildenafil 100 mg, though patient preference slightly favored vardenafil for tolerability (fewer visual disturbances and flushing episodes) [8].
The Staxyn formulation (vardenafil orally disintegrating tablet, 10 mg) offers an advantage for patients who prefer not to swallow pills or who want a more discreet dosing option. Staxyn dissolves on the tongue without water. It is not bioequivalent to the standard Levitra tablet, so the two formulations are not interchangeable milligram-for-milligram [1].
Generic pricing favors sildenafil and tadalafil slightly ($0.30 to $2.00 per tablet) over vardenafil ($1.50 to $4.00), but the difference narrows with discount programs. Generic Staxyn (orally disintegrating vardenafil) is not yet available; the brand product runs $40 to $60 per tablet.
Prior Authorization and Step Therapy in Arizona
When a commercial insurer or Medicare Part D plan covers vardenafil, prior authorization (PA) is the most common access barrier. Here is what the process looks like in Arizona.
Step 1: Prescriber submits PA request. The prescriber or their staff submits a PA form to the plan's PBM (Express Scripts, CVS Caremark, OptumRx, or others). The form requires the patient's diagnosis, duration of symptoms, prior treatments tried (and why they failed or were contraindicated), and relevant clinical data.
Step 2: PBM clinical review. A pharmacist or nurse reviewer evaluates the request against the plan's coverage criteria. Most plans require documentation that the patient tried generic sildenafil first unless a contraindication exists (for example, sildenafil-induced visual disturbance or severe flushing). A cardiovascular risk assessment and medication reconciliation confirming no nitrate use are standard requirements.
Step 3: Approval or denial. Turnaround averages 48 to 72 hours. If approved, the authorization typically covers 6 to 12 months. If denied, the prescriber can file a peer-to-peer appeal. Arizona Department of Insurance regulations require plans to process urgent PA requests within 24 hours.
Patients without insurance bypass this process entirely. Cash-pay pricing at retail pharmacies or through discount programs requires no prior authorization.
Transferring an Existing Vardenafil Prescription to Arizona
Patients relocating to Arizona from another state can transfer an active vardenafil prescription. Because vardenafil is not a controlled substance, the transfer process is straightforward under Arizona Board of Pharmacy rules.
The receiving Arizona pharmacy contacts the originating pharmacy, verifies the prescription details, confirms remaining refills, and processes the transfer. This typically takes 1 to 3 business days. E-prescribing networks like Surescripts can support electronic transfers in under 24 hours.
If the original prescription has no remaining refills, the patient needs a new prescription from an Arizona-licensed provider. Telehealth makes this simple. A patient can complete an online consultation, have the prescriber review their medication history from the state's Prescription Drug Monitoring Program (PDMP), and receive a new electronic prescription the same day.
Arizona participates in the NABP PMP InterConnect program, which means an Arizona prescriber can access PDMP data from most other states to verify the patient's existing vardenafil use and check for contraindicated co-prescriptions [9].
Timeline: From First Click to First Dose
Speed matters. Here is a realistic Arizona-specific timeline for a new patient starting vardenafil through telehealth.
Day 1: Complete an online intake form (10 to 15 minutes). Upload any existing lab results.
Day 1 to 2: Prescriber reviews the intake. If labs are needed, the platform orders them through a partner lab (Quest, Labcorp, or Sonora Quest in Arizona). Lab results return in 1 to 3 days.
Day 2 to 5: Prescriber conducts a synchronous or asynchronous review, writes the prescription, and sends it electronically to the patient's chosen pharmacy.
Day 2 to 7: Pharmacy fills the prescription. Retail pickup is same-day in most cases. Mail-order delivery adds 3 to 5 business days. 503A compounding pharmacies may require 5 to 7 business days for custom formulations.
Total time from intake to medication in hand: 2 to 12 days, depending on whether labs are required and which pharmacy pathway the patient selects. Patients with recent lab work and a synchronous video visit can receive a prescription within 24 hours and pick up from a local pharmacy the same day.
Safety Considerations Specific to Arizona Patients
Arizona's climate and demographics create a few practical considerations for vardenafil users. The state's high proportion of retirees (17.1% of the population is 65+, per the 2020 Census) means many vardenafil patients are also taking antihypertensives. Vardenafil has additive hypotensive effects with alpha-blockers like tamsulosin and doxazosin. The ACC/AHA 2017 hypertension guideline recommends separating PDE5 inhibitor and alpha-blocker dosing by at least 4 hours, and starting vardenafil at 5 mg in patients on alpha-blockers [10].
Dehydration is common in Arizona's desert climate, particularly during summer months when temperatures exceed 110°F. Dehydration can potentiate the hypotensive effects of PDE5 inhibitors. Patients should maintain adequate hydration, especially if combining vardenafil with antihypertensives or diuretics.
Arizona's altitude varies significantly. Patients living at higher elevations (Flagstaff sits at 6,910 feet) may notice slightly different hemodynamic responses to vasodilators. No dose adjustment is formally required, but patients at altitude with preexisting orthostatic hypotension should start at the 5 mg dose.
Vardenafil carries a low risk of priapism (prolonged erection lasting more than 4 hours). The incidence in clinical trials was <0.1%, but patients with sickle cell disease, multiple myeloma, or leukemia face higher risk [1]. Arizona emergency departments are equipped to manage priapism, but patients in remote areas of the state should be counseled on the urgency of seeking immediate care if an erection persists beyond 4 hours.
Frequently asked questions
›How do I get a vardenafil (Levitra/Staxyn) prescription in Arizona?
›What labs are needed before vardenafil in Arizona?
›Are there telehealth providers in Arizona prescribing vardenafil?
›How long until I receive vardenafil in Arizona?
›Can I transfer a vardenafil prescription to Arizona?
›Are 503A pharmacies in Arizona licensed to ship vardenafil?
›Who can prescribe vardenafil in Arizona: MD vs NP vs PA?
›What documentation does prior authorization require in Arizona?
›Is vardenafil covered by Arizona Medicaid (AHCCCS)?
›What is the difference between Levitra and Staxyn?
›Can I get vardenafil without insurance in Arizona?
›Does vardenafil interact with blood pressure medications?
References
- U.S. Food and Drug Administration. Levitra (vardenafil hydrochloride) prescribing information. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s020lbl.pdf
- Arizona State Legislature. ARS 32-2532: Physician assistant scope of practice. https://www.azleg.gov/ars/32/02532.htm
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- United States Pharmacopeia. USP General Chapter 795: Pharmaceutical compounding, nonsterile preparations. https://www.usp.org/compounding/general-chapter-795
- Mulhall JP, Giraldi A, Graziottin A, et al. Access to phosphodiesterase type 5 inhibitor prescriptions in commercially insured men. J Sex Med. 2019;16(8):1167-1174. https://pubmed.ncbi.nlm.nih.gov/31262711/
- Rubio-Aurioles E, Porst H, Eardley I, et al. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study. J Sex Med. 2006;3(6):1037-1049. https://pubmed.ncbi.nlm.nih.gov/17100938/
- National Association of Boards of Pharmacy. PMP InterConnect. https://nabp.pharmacy/initiatives/pmp-interconnect/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29133354/